A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Treatment Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid British shipping. Vendors market the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.
Some professionals said the demand for retatrutide could be linked to the rising cost of licensed slimming treatments such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Content Elimination
Based on the social media company, the platform has taken down violative material and prohibited related hashtags and search suggestions. The company said it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.
Digital Trading Activities
Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or administering at residence.
Within minutes of joining one community, a vendor posted WhatsApp details, where most purchases occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.
Item Details and Pricing
Inside these communities, posts display dark colored packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram stated it regularly monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.
Her staff has already encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may subject users to potentially serious medical dangers”.
